(Q36576605)

15 August 2017

1 reference

title

Cholecystokinin and treatment of meal size: proof of principle (English)

1 reference

15 August 2017

1 reference

1

Gerard P Smith

1 reference

15 August 2017

publication date

1 July 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

14 Suppl 4

1 reference

15 August 2017

page(s)

168S-170S

1 reference

Leptin and CCK selectively activate vagal afferent neurons innervating the stomach and duodenum

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Inhibitory effects on intake of cholecystokinin-8 and cholecystokinin-33 in rats with hepatic proper or common hepatic branch vagal innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Psychobiology of food preferences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

The direct and indirect controls of meal size

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

The controls of eating: a shift from nutritional homeostasis to behavioral neuroscience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Cholecystokinin decreases food intake in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Hormonal regulation of food intake.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Differential roles for cholecystokinin a receptors in energy balance in rats and mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

The role of gastrointestinal vagal afferents in the control of food intake: current prospects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Cholecystokinin induces c-fos expression in hypothalamic oxytocinergic neurons projecting to the dorsal vagal complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

c-Fos Expression in Rat Brain and Brainstem Nuclei in Response to Treatments That Alter Food Intake and Gastric Motility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

C-fos protein expression in the nucleus of the solitary tract correlates with cholecystokinin dose injected and food intake in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Exogenous cholecystokinin activates cFos expression in medullary but not hypothalamic neurons in neonatal rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

C-terminal octapeptide of cholecystokinin decreases food intake in man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

C-Terminal octapeptide of cholecystokinin decreases food intake in obese men☆☆☆

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Untangling the effects of hunger, anxiety, and nausea on energy intake during intravenous cholecystokinin octapeptide (CCK-8) infusion.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

The effect of cholecystokinin in controlling appetite and food intake in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Cholecystokinin suppresses sham feeding in the rhesus monkey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Rapid development of tolerance to the behavioural actions of cholecystokinin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Endogenous cholecystokinin reduces feeding in young rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Oral administration of proteinase inhibitor II from potatoes reduces energy intake in man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Bioactivity of intraduodenally and intravenously infused fragments of luminal cholecystokinin releasing factor (LCRF)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

Luminal CCK-releasing factor stimulates CCK release from human intestinal endocrine and STC-1 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.300

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.300

1 reference

15 August 2017

1 reference